Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: a systematic review and meta-analysis

The Lancet

Volumn 391, Issue 10117, 2018, Pages 241-250

  Aldridge, Robert W ^a   Story, Alistair ^a,b   Hwang, Stephen W ^c   Nordentoft, Merete ^d   Luchenski, Serena A ^a   Hartwell, Greg ^e   Tweed, Emily J ^f   Lewer, Dan ^a   Vittal Katikireddi, Srinivasa ^f   Hayward, Andrew C ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^f UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOLISM; ARTICLE; ASTHMA; CANNABIS ADDICTION; COMORBIDITY; DRUG DEPENDENCE; HEPATITIS B; HIGH INCOME COUNTRY; HIGH RISK POPULATION; HOMELESS PERSON; HOMELESSNESS; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; ISCHEMIC HEART DISEASE; LATENT TUBERCULOSIS; MENTAL HEALTH; META ANALYSIS; MORBIDITY; MORTALITY; MORTALITY RATE; PREVALENCE; PRIORITY JOURNAL; PRISONER; PROSTITUTION; RISK ASSESSMENT; SCHIZOPHRENIA; SEX DIFFERENCE; SEX WORKER; SYSTEMATIC REVIEW; DEVELOPING COUNTRY; HEALTH DISPARITY; SOCIAL EXCLUSION; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

DEVELOPED COUNTRIES; HEALTH STATUS DISPARITIES; HOMELESS PERSONS; HUMANS; MORBIDITY; MORTALITY; PRISONERS; SEX WORKERS; SOCIAL MARGINALIZATION; SOCIOECONOMIC FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 85033705847     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(17)31869-X     Document Type: Article

References (62)

1. Luchenski, S, Maguire, N, Aldridge, RW, et al. What works in inclusion health: overview of effective interventions for marginalised and excluded populations. Lancet, 2017 published online Nov 11. http://dx.doi.org/10.1016/S0140-6736(17)31959-1.
2. Bramley, G, Fitzpatrick, S, Edwards, J, et al. Hard edges: mapping severe and multiple disadvantage in England. http://lankellychase.org.uk/multiple-disadvantage/publications/hard-edges/, 2015 (accessed Dec 2, 2016).
3. Fazel, S, Bains, P, Doll, H, Substance abuse and dependence in prisoners: a systematic review. Addiction 101 (2006), 181–191.
4. Gilchrist, G, Singleton, N, Donmall, M, Jones, A, Prevalence and factors associated with sex trading in the year prior to entering treatment for drug misuse in England. Drug Alcohol Depend 152 (2015), 116–122.
5. Greenberg, GA, Rosenheck, RA, Homelessness in the state and federal prison population. Crim Behav Ment Health 18 (2008), 88–103.
6. Croxford, S, Platt, L, Hope, VD, Cullen, KJ, Parry, JV, Ncube, F, Sex work amongst people who inject drugs in England, Wales and Northern Ireland: findings from a national survey of health harms and behaviours. Int J Drug Policy 26 (2015), 429–433.
7. Fitzpatrick, S, Bramley, G, Johnsen, S, Pathways into multiple exclusion homelessness in seven UK cities. Urban Stud 50 (2013), 148–168.
8. Graham, L, Fischbacher, CM, Stockton, D, Fraser, A, Fleming, M, Greig, K, Understanding extreme mortality among prisoners: a national cohort study in Scotland using data linkage. Eur J Public Health 25 (2015), 879–885.
9. Arendt, M, Munk-Jørgensen, P, Sher, L, Jensen, SO, Mortality among individuals with cannabis, cocaine, amphetamine, MDMA, and opioid use disorders: a nationwide follow-up study of Danish substance users in treatment. Drug Alcohol Depend 114 (2011), 134–139.
10. Nielsen, SF, Hjorthøj, CR, Erlangsen, A, Nordentoft, M, Psychiatric disorders and mortality among people in homeless shelters in Denmark: a nationwide register-based cohort study. Lancet 377 (2011), 2205–2214.
11. Peace, R, Social exclusion: a concept in need of definition?. Soc Policy J N Z 16 (2001), 17–36.
12. Fitzpatrick, S, Bramley, G, Johnse, S, Multiple exclusion homelessness in the UK: an overview of key findings. http://mcnevaluation.co.uk/download/public/observatory/resource-type/research-evaluation/2012%20Multiple%20Exclusion%20Homelessness%20-%20breifing%20paper%201.pdf, 2012 (accessed Dec 2, 2016).
13. The World Bank. World Bank country and lending groups. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups (accessed Nov 2, 2016).
14. Higgins, JPT, Thompson, SG, Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002), 1539–1558.
15. Roy, É Haley, N, Boudreau, J-F, Leclerc, P, Boivin, J-F, The challenge of understanding mortality changes among street youth. J Urban Health 87 (2010), 95–101.
16. Vila-Rodriguez, F, Panenka, WJ, Lang, DJ, et al. The hotel study: multimorbidity in a community sample living in marginal housing. Am J Psychiatry 170 (2013), 1413–1422.
17. Kariminia, A, Butler, TG, Corben, SP, et al. Extreme cause-specific mortality in a cohort of adult prisoners—1988 to 2002: a data-linkage study. Int J Epidemiol 36 (2007), 310–316.
18. Bargagli, AM, Hickman, M, Davoli, M, et al. Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health 16 (2006), 198–202.
19. Barrio, G, Molist, G, de la Fuente, L, et al. Mortality in a cohort of young primary cocaine users: controlling the effect of the riskiest drug-use behaviors. Addict Behav 38 (2013), 1601–1604.
20. Bjornaas, MA, Bekken, AS, Ojlert, A, et al. A 20-year prospective study of mortality and causes of death among hospitalized opioid addicts in Oslo. BMC Psychiatry, 8, 2008, 8.
21. Darke, S, Mills, KL, Ross, J, Teesson, M, Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001–2009. Drug Alcohol Depend 115 (2011), 190–195.
22. Degenhardt, L, Larney, S, Randall, D, Burns, L, Hall, W, Causes of death in a cohort treated for opioid dependence between 1985 and 2005. Addiction 109 (2014), 90–99.
23. Evans, JL, Tsui, JI, Hahn, JA, Davidson, PJ, Lum, PJ, Page, K, Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study. Am J Epidemiol 175 (2012), 302–308.
24. Gibson, A, Randall, D, Degenhardt, L, The increasing mortality burden of liver disease among opioid-dependent people: cohort study. Addiction 106 (2011), 2186–2192.
25. Hser, YI, Kagihara, J, Huang, D, Evans, E, Messina, N, Mortality among substance-using mothers in California: a 10-year prospective study. Addiction 107 (2012), 215–222.
26. Lee, CTC, Chen, VCH, Tan, HKL, et al. Suicide and other-cause mortality among heroin users in Taiwan: a prospective study. Addict Behav 38 (2013), 2619–2623.
27. Mathers, BM, Degenhardt, L, Bucello, C, Lemon, J, Wiessing, L, Hickman, M, Mortality among people who inject drugs: a systematic review and meta-analysis. Bull World Health Organ 91 (2013), 102–123.
28. Merrall, ELC, Bird, SM, Hutchinson, SJ, Mortality of those who attended drug services in Scotland 1996–2006: record-linkage study. Int J Drug Policy 23 (2012), 24–32.
29. Nyhlen, A, Fridell, M, Hesse, M, Krantz, P, Causes of premature mortality in Swedish drug abusers: a prospective longitudinal study 1970–2006. J Forensic Leg Med 18 (2011), 66–72.
30. Nyhlen, A, Fridell, M, Backstrom, M, Hesse, M, Krantz, P, Substance abuse and psychiatric co-morbidity as predictors of premature mortality in Swedish drug abusers a prospective longitudinal study 1970–2006. BMC Psychiatry, 11, 2011, 122.
31. Pavarin, RM, Mortality risk for cocaine abusers in relation to heroin use: a follow-up study. Subst Use Misuse 48 (2013), 702–710.
32. Rehm, J, Frick, U, Hartwig, C, Gutzwiller, F, Gschwend, P, Uchtenhagen, A, Mortality in heroin-assisted treatment in Switzerland 1994–2000. Drug Alcohol Depend 79 (2005), 137–143.
33. Rosca, P, Haklai, Z, Goldberger, N, Zohar, P, Margolis, A, Ponizovsky, AM, Mortality and causes of death among users of methadone maintenance treatment in Israel, 1999–2008. Drug Alcohol Depend 125 (2012), 160–163.
34. Singleton, J, Degenhardt, L, Hall, W, Zabransky, T, Mortality among amphetamine users: a systematic review of cohort studies. Drug Alcohol Depend 105 (2009), 1–8.
35. Spittal, PM, Hogg, RS, Li, K, et al. Drastic elevations in mortality among female injection drug users in a Canadian setting. AIDS Care 18 (2006), 101–108.
36. Stoové MA, Dietze, PM, Aitken, CK, Jolley, D, Mortality among injecting drug users in Melbourne: a 16-year follow-up of the Victorian Injecting Cohort Study (VICS). Drug Alcohol Depend 96 (2008), 281–285.
37. van Santen, DK, van der Helm, JJ, Grady, BPX, et al. Temporal trends in mortality among people who use drugs compared with the general Dutch population differ by hepatitis C virus and HIV infection status. AIDS 28 (2014), 2589–2599.
38. Zabransky, T, Csemy, L, Grohmannova, K, Janikova, B, Brenza, J, Mortality of cohort of very young injecting drug users in Prague, 1996–2010. Cent Eur J Public Health 19 (2011), 152–157.
39. Degenhardt, L, Singleton, J, Calabria, B, et al. Mortality among cocaine users: a systematic review of cohort studies. Drug Alcohol Depend 113 (2011), 88–95.
40. Degenhardt, L, Randall, D, Hall, W, Law, M, Butler, T, Burns, L, Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug Alcohol Depend 105 (2009), 9–15.
41. Gilles, M, Swingler, E, Craven, C, Larson, A, Prison health and public health responses at a regional prison in Western Australia. Aust N Z J Public Health 32 (2008), 549–553.
42. Des Jarlais, DC, Perlis, T, Arasteh, K, et al. Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001. AIDS 19:suppl 3 (2005), S20–S25.
43. del Amo, J, González, C, Losana, J, et al. Influence of age and geographical origin in the prevalence of high risk human papillomavirus in migrant female sex workers in Spain. Sex Transm Infect 81 (2005), 79–84.
44. Havens, JR, Walker, R, Leukefeld, CG, Prevalence of opioid analgesic injection among rural nonmedical opioid analgesic users. Drug Alcohol Depend 87 (2007), 98–102.
45. Bart, G, Piccolo, P, Zhang, L, Jacobson, I, Schaefer, RA, Kreek, MJ, Markers for hepatitis A, B and C in methadone maintained patients: an unexpectedly high co-infection with silent hepatitis B. Addiction 103 (2008), 681–686.
46. Carbonara, S, Babudieri, S, Longo, B, et al. Correlates of Mycobacterium tuberculosis infection in a prison population. Eur Respir J 25 (2005), 1070–1076.
47. Tabuchi, T, Takatorige, T, Hirayama, Y, et al. Tuberculosis infection among homeless persons and caregivers in a high-tuberculosis-prevalence area in Japan: a cross-sectional study. BMC Infect Dis, 11, 2011, 22.
48. Prinsloo, B, Parr, C, Fenton, J, Mental illness among the homeless: prevalence study in a Dublin homeless hostel. Ir J Psychol Med 29 (2012), 22–26.
49. Lubman, DI, Allen, NB, Rogers, N, Cementon, E, Bonomo, Y, The impact of co-occurring mood and anxiety disorders among substance-abusing youth. J Affect Disord 103 (2007), 105–112.
50. Baillargeon, J, Penn, JV, Thomas, CR, Temple, JR, Baillargeon, G, Murray, OJ, Psychiatric disorders and suicide in the nation's largest state prison system. J Am Acad Psychiatry Law 37 (2009), 188–193.
51. Vergara-Moragues, E, González-Saiz, F, Lozano, OM, et al. Psychiatric comorbidity in cocaine users treated in therapeutic community: substance-induced versus independent disorders. Psychiatry Res 200 (2012), 734–741.
52. Darke, S, Williamson, A, Ross, J, Teesson, M, Attempted suicide among heroin users: 12-month outcomes from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend 78 (2005), 177–186.
53. Brown, RT, Kiely, DK, Bharel, M, Mitchell, SL, Geriatric syndromes in older homeless adults. J Gen Intern Med 27 (2012), 16–22.
54. Harzke, AJ, Baillargeon, JG, Pruitt, SL, Pulvino, JS, Paar, DP, Kelley, MF, Prevalence of chronic medical conditions among inmates in the Texas prison system. J Urban Health 87 (2010), 486–503.
55. O'Brien, KK, Schuttke, A, Alhakeem, A, et al. Health, perceived quality of life and health services use among homeless illicit drug users. Drug Alcohol Depend 154 (2015), 139–145.
56. Romeri, E, Baker, A, Griffiths, C, Mortality by deprivation and cause of death in England and Wales, 1999–2003. Health Stat Q 32 (2006), 19–34.
57. Kapilashrami, A, Hill, S, Meer, N, What can health inequalities researchers learn from an intersectionality perspective? Understanding social dynamics with an inter-categorical approach?. Soc Theory Health 13 (2015), 288–307.
58. Ioannidis, JPA, Patsopoulos, NA, Rothstein, HR, Reasons or excuses for avoiding meta-analysis in forest plots. BMJ 336 (2008), 1413–1415.
59. Marmot, M, Fair society, healthy lives: the Marmot Review: strategic review of health inequalities in England post-2010. https://www.gov.uk/dfid-research-outputs/fair-society-healthy-lives-the-marmot-review-strategic-review-of-health-inequalities-in-england-post-2010, 2010 (accessed Oct 22, 2017).
60. Katikireddi, SV, Valles, SA, Coupled ethical-epistemic analysis of public health research and practice: categorizing variables to improve population health and equity. Am J Public Health 105 (2015), e36–e42.
61. Aldridge, RW, Shaji, K, Hayward, AC, Abubakar, I, Accuracy of probabilistic linkage using the enhanced matching system for public health and epidemiological studies. PloS One, 10, 2015, e0136179.
62. Barnett, K, Mercer, SW, Norbury, M, Watt, G, Wyke, S, Guthrie, B, Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380 (2012), 37–43.